Please login to the form below

Not currently logged in
Email:
Password:

DH names new chief executive of the MHRA

Ian Hudson to lead UK medicines regulator

MHRA CHMP Dr Ian Hudson

Dr Ian Hudson has been appointed as the new chief executive of the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).

Hudson has been with the regulator since 2001 and is currently its licensing director. He will assume the new position in September, when Sir Kent Woods steps down after ten years with the agency.

“Dr Hudson is used to working to the highest possible standards and maintaining the very toughest scrutiny over a fast-moving industry and I am confident he will find this role a deeply rewarding challenge,” commented health minister Lord Howe.

Hudson is also the UK delegate and vice chairman of the Committee on Human Medicinal Products (CHMP) at the European Medicines Agency.

Commenting on his new appointment he said: “The MHRA plays a critical role in ensuring that medicines and medical devices help people and are acceptably safe; we support research and development; and protect and promote the health of millions of people through our activities.

“Sir Kent has led the MHRA very effectively and has developed it into one of the leading medicines and medical devices regulators in the world,” he added.

The decision follows the arrival of Gordon Duff to the agency, who joined in January this year as a non-executive director.

Duff said: “Dr Hudson has excellent, broad experience across all aspects of medicines regulation and is ideally placed to lead the MHRA, which is unique in bringing together medicines and medical devices regulation together with world-class research facilities and expertise.”

5th July 2013

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics